Nonetheless, loss of EAAT2 function increases the activity of insulin-degrading enzymes in the liver, suggesting that the loss of EAATs causes insulin/protein kinase B signaling abnormalities in AD [83]. Here, SLC1A2 is linked to Alzheimer disease.